MMP2 and nonpapillary renal cell carcinoma: Using a zymography technique, our previous study showed that MMP-9 is enhanced in the sera from ccRCC patients compared with that from oncocytoma patients, and that the most abundant lytic activity was at 92 kDa (MMP-9), whereas MMP-2 was present in reduced quantities (12).